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Recent achievements in scaling up paediatric antiretroviral therapy (ART) have changed the life of children living
with HIV, who now stay healthy and live longer lives. However, as it becomes more of a chronic infection, a range
of new problems have begun to arise. These include the disclosure of HIV serostatus to children, adherence to
ART, long-term toxicities of antiretroviral drugs and their sexual and reproductive health, which are posing
significant challenges to the existing health systems caring for children with HIV with limited resources,
experiences and capacities. While intensified efforts and actions to improve care and treatment for these children
are needed, it is crucial to accelerate the prevention of mother-to-child transmission (PMTCT) of HIV, which is
the main cause of paediatric HIV in the ASEAN region so as to eliminate the fundamental cause of the problem.
This report argues that given over 70% of women have access to at least one antenatal care visit in the region and
acceptance of HIV testing after receiving counselling on PMTCT could be as high as 90%, there is an opportunity
to strengthen PMTCT services and eventually eliminate new paediatric HIV infections in the ASEAN countries.
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Introduction
Of the two million children under 15 estimated to be
living with HIV globally, 160,000 of them live in Asia
and the Pacific. Among them 30,000 children were
receiving antiretroviral therapy (ART) in 2008 with a
proportion of them on treatment for several years
(UNICEF, UNAIDS, WHO, & UNFPA, 2009).
Recent achievements in scaling up services for the
provision of paediatric ART have changed the life of
children living with HIV; they can stay healthy, live
longer lives and also attend school. However, as HIV
infection becomes more of a chronic condition, a
range of new problems and challenges have begun to
arise.
The ASEAN and Japan HIV/AIDS workshop
(ASEAN AIDS workshop) which aims at sharing the
experiences and exploring possible solutions for
common challenges among ASEAN member coun-
tries, namely Brunei Darussalam, Cambodia, Indo-
nesia, the Lao People’s Democratic Republic,
Malaysia, Myanmar, the Philippines, Singapore,
Thailand and Viet Nam, has been organised annually
since the year 2003 hosted by the Ministry of Health,
Labour and Welfare Japan. The sixth ASEAN AIDS
workshop was held in Tokyo in February 2009 with
participants from ASEAN member countries, World
Health Organization Regional Office for the Western
Pacific, the National Center for Global Health and
Medicine and the Ministry of Health, Labour and
Welfare Japan. Paediatric HIV and prevention of
mother-to-child transmission (PMTCT) of HIV was
the one of the main issues discussed during the
workshop.
Currently, relatively few initiatives have drawn
attention on the issues of paediatric HIV and
PMTCT of HIV in the region despite serious
challenges they face and their negative consequences
on children. The aim of this report is to highlight
these issues by drawing the discussions and conclu-
sions reached in the ASEAN AIDS workshop and the
review of the existing evidences, and to contribute to
the ongoing efforts to eliminate mother-to-child
transmission of HIV, thus virtually eliminating pae-
diatric HIV in the region.
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Four major challenges on paediatric HIV care,
support and treatment were raised and discussed
during the workshop. The first issue concerned with
the disclosure of HIV serostatus to children, a highly
complex issue as also reported by several authors
(Lesch et al., 2007; Wiener, Mellins, Marhefka, &
Battles, 2007). The participants reported that the
challenges often combine the reluctance of families to
disclose HIV infection to their children together with
a limited experience of health care providers in
managing this critical step. Although most countries
represented in the workshop have reportedly set
10 years of age as the time for disclosure, doubts
about its appropriateness were voiced by participants,
along with concerns related to a lack of experience
and confidence about the process of disclosure. The
workshop agreed that the most appropriate time
would be when children start asking questions
regarding their condition and reasons for the treat-
ment, and that disclosure should be done gradually
and through age-sensitive approaches and contents.
The second issue referred to adherence to anti-
retroviral (ARV) treatment. It was stated that rela-
tively high rates of adherence are currently reported
among young children, whose compliance almost
entirely relies on their caregivers. However, it appears
that adherence gradually decreases as these children
become adolescents, and accordingly assume more
responsibility for their medication-taking. Adoles-
cents often discontinue medication due to medication
fatigue (Saitoh et al., 2008), which was also reported
from the workshop participants. It is also known that
adolescents sometimes use non-adherence to medica-
tion as a way to express their autonomy (Simoni
et al., 2007). Moreover, appearance change due to
lipoatrophy or even the perception of this potential
risk could lead adolescents to discontinue medication
(DeLaMora, Aledort, & Stavola, 2006). Keeping
adherence rates among paediatric patients, especially
adolescents, continues to pose a major challenge.
Thirdly, as children living with HIV grow into
adolescents, sexual health becomes a significant issue
of concern. They start to develop intimate relation-
ships, which bring new complex issues, such as
disclosure of their HIV status to their boyfriend/
girlfriend, fear of stigmatisation and discrimination,
and risk of transmission of HIV infection (Thorne
et al., 2002). Furthermore, it was reported that in
some western countries their perspective marriage,
pregnancy and parenting were raising additional
challenges and concerns.
Fourth, long-term toxicities of ARV drugs, such
as mitochondrial toxicity and metabolic abnormality,
are of significant relevance for paediatric cases, as
length of treatment may be expected to span several
decades. A WHO survey found that in Cambodia,
among 3236 children who were on the first line
regimens in 2009, 3058 (94.5%) of them were on
regimens including d4T and in Viet Nam, 1324
children among 1817 (72.9%) were on regimens
including d4T (WHO, 2010). Since the majority of
children are younger than 10 years of age, it is
expected that most of them may experience d4T-
related toxicities such as lipoatrophy as they become
teenagers. As mentioned above, lipoatrophy is
reported as one of the main obstacles to drug
adherence among adolescents in developed countries
(DeLaMora et al., 2006). As the new WHO guidelines
recommend phasing out the use of d4T (WHO,
2009a), awareness of this potential risk should be
raised and strategies for more appropriate regimen
choices should be discussed.
As argued above, paediatric HIV is already
confronted with several challenges; it is expected
that these problems could become more complex in
the future as children grow into adolescents and
young adults. Continuous, dedicated efforts and
infinite patience from children themselves as well as
support from family and health care providers are
necessary to keep and achieve high adherence to
ART. Drug toxicities are unavoidable unless new less
toxic ARVs are produced and made available at
affordable cost for resource-limited settings. Psycho-
social impact related to HIV infection in children is
immense and immeasurable, which may affect them
not only psychologically but also socially, for exam-
ple, by affecting their relationships with others and
their future opportunities. This workshop agreed that
all these challenges require immediate attentions and
dedicated efforts are urgently needed to overcome
these seemingly inextricable difficulties.
Strengthening prevention of mother-to-child
transmission (PMTCT) of HIV
While intensified efforts and actions to improve care,
support and treatment for children living with HIV
are needed urgently, it is fundamental and crucial to
strengthen HIV prevention and stop new infection
from occurring among children. Since over 90% of
new HIV infections among infants and young children
occur through mother-to-child transmission of HIV
(WHO & UNICEF, 2007), it is obvious that preven-
tion remains the top priority. It is well-documented
that focused and well-established interventions for
414 N. Ishikawa et al.PMTCT have virtually eliminated paediatric HIV in
high-income countries, with antenatal care (ANC)
playing an important role as a platform for HIV
testing and provision of prevention services (WHO &
UNICEF, 2007).
As shown in Table 1, although most countries
report high-ANC coverage ranging from 70% to over
90% (UNICEF et al., 2009), coverage of PMTCT
service in this region remains low with estimated
coverage of 25% in average (WHO, UNAIDS, &
UNICEF, 2009). This indicates that weak PMTCT
services and low coverage rates are leaving mother-to-
child transmission of HIV largely unabated and
resulted in high number of new paediatric infections,
which in turn aggravate the complex problems related
to the management of paediatric HIV, especially in
settings where available expertise for such services
is quite limited. In the absence of stronger and
more effective PMTCT services, it is expected that the
number of children with HIV will continue to increase
and pose additional challenges to health systems.
One of the reasons suggested to explain the low
coverage of PMTCT services is the dominance of
treatment and care over prevention in HIV control
efforts (Horton & Das, 2008). Other reasons include
limited financial and human resources (Paintsil &
Andiman, 2009); fragile maternal, newborn, and child
health (MNCH) services; low acceptance of HIV
testing due to the poor quality of services; limi-
ted information; lack of access to ART (Dahl,
Mellhammar, Bajunirwe, & Bjorkman, 2008); and
problems related to the involvement of male partners
(Kakimoto et al., 2007). Moreover, weak coordina-
tion within ministries of health and among public
health programmes, often caused by incoherent
policies, financing and institutional mechanisms, is
often recognised as a significant factor (Druce &
Nolan, 2007).
However, there is now an effort to strengthen
PMTCT services in the region by linking HIV and
MNCH services by applying the AsiaPacific opera-
tional framework for linking HIV/STI services with
reproductive, adolescent, MNCH services, which is
known as Guilin Framework (WHO, UNICEF,
UNFPA, & UNAIDS, 2008) with some promising
success in some countries. The AsiaPacific United
Nations task force for the prevention of parent-to-
child transmission of HIV has also strongly com-
mitted to pursue the virtual elimination of paediatric
HIV in the region.
Call to action
Given that over 70% of women have access to at least
one ANC visit in the region, and acceptance of HIV
testing after receiving counselling for PMTCT could
be as high as 90% (Kakimoto et al., 2007; Pai et al.,
2008), there is an opportunity to strengthen PMTCT
services, all the more so in the ASEAN region with
low HIV prevalence and a relatively well-established
health infrastructure compared to other resource-
limited countries. Drawing from successful experi-
ences of countries like Thailand, where rates of new
HIV infections through mother-to-child transmission
have been dramatically reduced from 6.4% in 2001 to
1.3% in 2006 (National AIDS prevention and allevia-
tion committee, 2008), the workshop recognised
political commitment and full integration of PMTCT
Table 1. Prevention of mother-to-child transmission of HIV in the ASEAN region.
Estimated adult HIV
prevalence rate
(%, 1549 years), 2007
a
ANC coverage
(%), 20032008
a
Percentage of pregnant women
with HIV who received ARVs
for PMTCT: lowhigh
estimates (%), 2008
b
Children (014 years)
living with HIV, 2007
a
Brunei
Darussalam
  
Cambodia 0.8 69 35  95 4400
Indonesia 0.2 93 415 4360
c
Lao PDR 0.2 35 828 
Malaysia 0.5 79 1039 
Myanmar 0.7  1465 
Philippines  91 B115 0
c
Singapore 0.2  
Thailand 1.4 98 33  95 14,000
Viet Nam 0.5 91 2787 3055
c
aSee UNICEF et al. (2009).
bSee WHO et al. (2009).
cThe sixth ASEAN and Japan HIV/AIDS Workshop 2009 country report.
AIDS Care 415services into well-organised MNCH care systems as a
key to success.
With the new WHO rapid advice on use of ARV
drugs for treating pregnant women and preventing
HIV infection in infants recommending the use of
more efficacious ARV regimens (WHO, 2009b), it is
believed that through close linkage and collaboration
between HIV and MNCH programmes sustained by
strong political commitment and joint effort from all
the stakeholders, elimination of paediatric HIV in the
ASEAN region is an achievable goal.
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